Exact Mass: 1226.538991
Exact Mass Matches: 1226.538991
Found 32 metabolites which its exact mass value is equals to given mass value 1226.538991,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Terlipressin
C52H74N16O15S2 (1226.4960734000001)
H - Systemic hormonal preparations, excl. sex hormones and insulins > H01 - Pituitary and hypothalamic hormones and analogues > H01B - Posterior pituitary lobe hormones > H01BA - Vasopressin and analogues C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C80212 - Antidiuretic Hormone Analogue D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents > D014667 - Vasopressins D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Yayoisaponin B
Yayoisaponin B is found in onion-family vegetables. Yayoisaponin B is a constituent of mutant of Allium ampeloprasum (great-head garlic). Constituent of mutant of Allium ampeloprasum (great-head garlic). Yayoisaponin B is found in onion-family vegetables.
Terlipressin
C52H74N16O15S2 (1226.4960734000001)
Terlipressin is only found in individuals that have used or taken this drug. It is an analogue of vasopressin used as a vasoactive drug in the management of hypotension. It has been found to be effective when norepinephrine does not help. [Wikipedia]Terlipressin acts on three different receptors, vasopressin receptor V1a (which initiates vasoconstriction, liver gluconeogenesis, platelet aggregation and release of factor VIII), vasopressin receptor V1b (which mediates corticotrophin secretion from the pituitary) and vasopressin receptor V2 which controls free water reabsorption in the renal medullar. The binding of terlipressin to the V2 receptor activates adenylate cyclase which causes the release of aquaporin 2 channels into the cells lining the renal medullar duct. This allows water to be reabsorbed down an osmotic gradient so the urine is more concentrated. H - Systemic hormonal preparations, excl. sex hormones and insulins > H01 - Pituitary and hypothalamic hormones and analogues > H01B - Posterior pituitary lobe hormones > H01BA - Vasopressin and analogues C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C80212 - Antidiuretic Hormone Analogue D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents > D014667 - Vasopressins D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Glypressin;Gly Gly Gly 8 Lys vasopressin
C52H74N16O15S2 (1226.4960734000001)
(25R)-2??,15??-Dihydroxyspirost-5-en-3??-yl O-??-D-glucopyranosyl- (1鈥樏傗垎3)-O-??-D-glucopyranosyl-(1鈥樏傗垎2)-O-[??-D-xylopyranosyl-(1鈥樏傗垎3)]-O-??-D-glucopyranosyl-(1鈥樏傗垎4)-??-D-galactopyranoside
(25R)-2alpha,17alpha-Dihydroxyspirost-5-en-3beta-yl O-beta-D-glucopyranosyl-(1->3)-O-beta-D-glucopyranosyl-(1->2)-O-[beta-D-xylopyranosyl-(1->3)]-O-beta-D-glucopyranosyl-(1->4)-beta-D-galactopyranoside
(25R)-26-O-beta-D-glucopyranosyl-furost-5-ene-12-one-3beta,22alpha,26-triol-3-O-beta-D-glucopyranosyl-(1?2)-[beta-D-xylopyranosyl-(1?3)]-beta-D-glucopyranosyl-(1?4)-beta-D-galactopyranoside|typaspidoside A
3beta-[(O-beta-D-glucopyranosyl)(1->6)-beta-D-glucopyranosyl)oxy)]-17alpha-hydroxy-16beta-[(O-(2-O-3,4-dimethoxybenzoyl-beta-D-xylopyranosyl)-(1->3)-2-O-acetyl-alpha-L-arabinopyranosyl)oxy]cholest-5-en-22-one
Yayoisaponin B
Glypressin;Gly Gly Gly 8 Lys vasopressin
C52H74N16O15S2 (1226.4960734000001)
D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents > D014667 - Vasopressins D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
3beta-[(O-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl)oxy]-17alpha-hydroxy-16beta-[(O-(2-O-3,4-dimethoxybenzoyl-beta-D-xylopyranosyl)-(1->3)-2-O-acetyl-alpha-L-arabinopyranosyl)oxy]cholest-5-en-22-one
A steroid saponin isolated from Ornithogalum thyrsoides and has been shown to exhibit antineoplastic activity.
(2s,3r,4s,5r)-2-{[(2s,3r,4s,5s)-2-{[(1s,2s,3as,3br,7s,9ar,9bs,11as)-1-hydroxy-9a,11a-dimethyl-1-[(2s)-6-methyl-3-oxoheptan-2-yl]-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl]oxy}-3-(acetyloxy)-5-hydroxyoxan-4-yl]oxy}-4,5-dihydroxyoxan-3-yl 3,4-dimethoxybenzoate
[6-({6-[4-(acetyloxy)-4-methylpentyl]-10-hydroxy-2,6,13,17,17-pentamethyl-8-oxo-7-oxapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icos-1(20)-en-16-yl}oxy)-5-({5-[(4-{[3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy]-3,4-dihydroxy-6-methyloxan-2-yl}oxy)-4-hydroxyoxan-3-yl]oxidanesulfonic acid
(2s,3r,4s,5s,6r)-2-{[(2s,3r,4s,5r,6r)-2-{[(2s,3r,4s,5r,6r)-2-{[(2r,3r,4r,5r,6r)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(1'r,2r,2's,4's,5r,7's,8's,9's,12's,13'r,15'r,16'r)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-8',15'-dioloxy]oxan-3-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-4-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(25r)-2α,15β-dihydroxyspirost-5-en-3β-ylo-β-d-glucopyranosyl-(1→3)-o-β-d-glucopy-ranosyl-(1→2)-o-[β-d-xylopyranosyl-(1→3)]-o-β-d-glucopyranosyl-(1→4)-β-d-galactopy-ranoside
{"Ingredient_id": "HBIN004725","Ingredient_name": "(25r)-2\u03b1,15\u03b2-dihydroxyspirost-5-en-3\u03b2-ylo-\u03b2-d-glucopyranosyl-(1\u21923)-o-\u03b2-d-glucopy-ranosyl-(1\u21922)-o-[\u03b2-d-xylopyranosyl-(1\u21923)]-o-\u03b2-d-glucopyranosyl-(1\u21924)-\u03b2-d-galactopy-ranoside","Alias": "NA","Ingredient_formula": "C56H90O29","Ingredient_Smile": "CC1CCC2(C(C3C(O2)C(C4C3(CCC5C4CC=C6C5(CC(C(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)CO)O)OC9C(C(C(CO9)O)O)O)OC2C(C(C(C(O2)CO)O)OC2C(C(C(C(O2)CO)O)O)O)O)O)O)O)C)C)O)C)OC1","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6128","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(25r)-2α,17α-dihydroxyspirost-5-en-3β-yl o-β-d-glucopyranosyl-(1→3)-o-β-d-glucopyra-nosyl-(1→2)-o-[β-d-xylopyranosyl-(1→3)]-o-β-d-glucopyranosyl-(1→4)-β-d-galactopy-ranoside
{"Ingredient_id": "HBIN004727","Ingredient_name": "(25r)-2\u03b1,17\u03b1-dihydroxyspirost-5-en-3\u03b2-yl o-\u03b2-d-glucopyranosyl-(1\u21923)-o-\u03b2-d-glucopyra-nosyl-(1\u21922)-o-[\u03b2-d-xylopyranosyl-(1\u21923)]-o-\u03b2-d-glucopyranosyl-(1\u21924)-\u03b2-d-galactopy-ranoside","Alias": "NA","Ingredient_formula": "C56H90O29","Ingredient_Smile": "CC1CCC2(C(C3(C(O2)CC4C3(CCC5C4CC=C6C5(CC(C(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)CO)O)OC9C(C(C(CO9)O)O)O)OC2C(C(C(C(O2)CO)O)OC2C(C(C(C(O2)CO)O)O)O)O)O)O)O)C)C)O)C)OC1","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6127","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}